MedPath

Mesna

These highlights do not include all the information needed to use MESNA INJECTION safely and effectively.  See full prescribing information for MESNA INJECTION . MESNA injection, for intravenous use Initial U.S. Approval: 1988

Approved
Approval ID

a7af968c-05cf-4438-94ba-96a2baf9c367

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 7, 2022

Manufacturers
FDA

Gland Pharma Limited

DUNS: 918601238

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Mesna Injection

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68083-161
Application NumberANDA206992
Product Classification
M
Marketing Category
C73584
G
Generic Name
Mesna Injection
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 7, 2022
FDA Product Classification

INGREDIENTS (4)

BENZYL ALCOHOLInactive
Quantity: 1.04 mg in 1 mL
Code: LKG8494WBH
Classification: IACT
EDETATE DISODIUMInactive
Quantity: 0.25 mg in 1 mL
Code: 7FLD91C86K
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
MESNAActive
Quantity: 100 mg in 1 mL
Code: NR7O1405Q9
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.